2015

There is a growing movement in Congress to push the Department of Health and Human Services (HHS) to postpone Stage 3 of the…

Yesterday, the Food and Drug Administration (FDA) released much anticipated guidance on how they plan to address nonproprietary…

Last week, the Federal Trade Commission (FTC) recommended that the Food and Drug Administration (FDA) consider…

A recent article in Reuters shed an interesting and potentially disturbing light on the “medical lending” industry,…

Yesterday, British Health Secretary Jeremy Hunt announced that all National Health Service hospitals and General…

 New York’s Attorney General recently announced an agreement with Purdue Pharma, the manufacturer of OxyContin, that…

As we previously published, on July 15, 2015, the Centers for Medicare & Medicaid Services (CMS) published its proposed rule…

  Earlier this week, Amgen Inc. agreed to pay $71 million to 48 states to settle allegations that it violated state consumer…

Hundreds of people flocked to Washington, DC this week for a three-day conference on Open Payments reporting and…

Could the Sunshine Act be creating an unintentional downward trend in clinical research? An analysis of the U.S. government’s…